ArticleInfectious diseases & clinical microbiology2025
Crimean-Congo Hemorrhagic Fever Disease: Relationship Between Clinical Course and Apoptosis.
Article in Infectious diseases & clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic disease that causes significant morbidity and mortality. This study aimed to evaluate the levels of apoptosis biomarkers-clusterin, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), caspase-8, cytochrome C, and apoptotic protease-activating factor 1 (Apaf-1)-in patients with mild and severe clinical presentations of CCHF, and to assess their relationship with disease severity. Materials and Methods: The study included adult patients admitted to our hospital with a confirmed diagnosis of CCHF. Patients were divided into two groups (mild and severe) based on the Severity Grading Score. Blood samples were analyzed for apoptosis markers using the enzyme-linked immunosorbent assay (ELISA) method. Apoptosis protein levels were measured separately during the acute and convalescent periods of the disease for both mild and severe cases. Results: A total of 49 patients were included in the study. In patients with a mild disease course, TRAIL levels were significantly higher during the acute period compared to the convalescent period ( Conclusions: Apoptosis and apoptosis-related proteins play an important role in the pathogenesis of CCHF. In particular, clusterin and TRAIL may serve as useful indicators of disease severity. Their early detection could improve clinical management by enabling timely intervention for patients at risk of severe disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.